查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2103672

腦植入市場：全球市場預測，2026-2032年

Brain Implants Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腦植入市場將成長至 105.1 億美元，複合年成長率為 9.43%。

主要市場統計數據
基準年 2025 55.9億美元
預計年份：2026年 61億美元
預測年份 2032 105.1億美元
複合年成長率 (%) 9.43%

腦植入是一種可植入的神經技術設備，它直接連接到神經組織，用於記錄、刺激、調節或恢復神經系統的功能。該領域涵蓋了用於治療運動障礙的深部腦刺激、用於治療癲癇的反應性神經刺激、人工電子耳耳蝸和視網膜假人工替代物的概念、脊髓和大腦皮層介面，以及用於通訊和運動控制的新型腦機介面系統。推動腦植入物市場需求的因素包括：神經系統疾病負擔日益加重、人口老化、神經外科手術精度的提高、電子設備的微型化、無線遙測技術、可充電電源系統、生物相容性材料，以及基於神經調節的治療途徑的臨床證據不斷累積。同時，腦植入領域仍受到嚴格監管，因為安全性、長期耐用性、網路安全、可解釋性、知情同意和植入後監測對患者的治療效果至關重要。行業相關人員越來越關注臨床檢驗的適應症、人性化的設計、保險報銷、真實世界數據 (REW) 生成以及神經病學、神經外科、精神病學、復健、生物醫學工程和數位健康等跨學科合作。

腦植入領域的變革性變化

腦植入領域正從以設備為中心的介入轉向整合的神經治療生態系統。傳統的開放回路刺激正閉合迴路和自適應系統所補充，這些系統能夠感知神經活動，並根據患者的個別訊號調整治療參數。這種轉變對於症狀隨時間波動的疾病尤其重要，例如帕金森氏症、癲癇、憂鬱症和慢性疼痛。微電極陣列、軟性神經探針、密封封裝、低功耗晶片和無線資料傳輸技術的進步，提高了長期植入的可行性，同時減輕了臨床程式設計的負擔。另一個顯著的變化是植入式設備與雲端連接的臨床工作流程、遠端監測、數位生物標記和精準成像的融合。監管機構也越來越重視上市後監管、軟體生命週期管理、網路安全措施、可用性工程以及持續臨床療效的證據。隨著腦機介面從實驗性的概念驗證發展到功能性通訊和運動輔助應用，關於自主性、神經元資料隱私、身分、公平取得以及「增強」和「治療」之間的區別的倫理管治，正成為其實施過程中的關鍵因素。

人工智慧對腦植入的累積影響

人工智慧正日益融入整個腦植入價值鏈，從訊號解碼和自適應刺激到手術規劃和長期照護最佳化。在研發領域，機器學習正在協助解讀複雜的神經記錄、識別生物標記、建立癲癇預測模型、進行運動狀態分類、語音解碼，並為每位患者量身定做個人化治療方案。在臨床實踐中，人工智慧工具可以輔助分析電生理模式、影像數據和症狀日記，從而支持程序制定決策並提高治療管理的一致性。最顯著的累積影響體現在封閉回路型神經調控方面，演算法可以將即時神經訊號轉化為動態刺激調控，從而在最大限度減少副作用和能耗的同時，提高治療的準確性。然而，人工智慧的引入也帶來了新的挑戰，例如檢驗、透明度、偏差評估、資料來源、網路安全、人因工程測試以及臨床醫生的監督。由於神經數據可以揭示有關認知、情感和行為的敏感信息，因此，腦植入中的人工智慧管治必須在整個設備生命週期中解決隱私、同意、可審計性和人為控制等問題，而不僅僅遵守傳統醫療設備的規定。

關於腦植入的關鍵區域性見解

在亞太地區，由於植入基礎設施的不斷完善、神經系統疾病患者數量龐大、政府對醫療技術的大力投入，以及中國、日本、韓國、印度和澳洲等國活性化開展的臨床研究，腦植入領域正迅速發展。北美地區憑藉其完善的神經外科中心、早期臨床試驗活動、已獲批准的臨床實驗醫療設備核准流程、針對已批准的神經調控適應症的健全保險報銷體系，以及針對高風險醫療設備的成熟法規結構，仍然是植入式神經技術領域的重要影響區域。拉丁美洲的主要都市區能夠獲得先進的神經系統醫療服務，其中巴西和墨西哥在引入專業治療方面發揮了重要作用，但成本效益、保險報銷差異以及神經外科專家分佈不均仍然是實際的限制因素。歐洲受益於統一的臨床標準、強大的神經科學學術網路、資料保護要求和健全的醫療設備法規，同時人口老化和重視實證醫學、安全性和成本效益的公共醫療體係也為其發展提供了支持。在中東，尤其是在海灣國家，人們正增加對專科醫院、醫療旅遊和先進神經科服務的投資，但全部區域擴張取決於人力資源開發、跨境臨床夥伴關係以及永續的保險報銷系統。在非洲，長期需求主要源於神經系統疾病的負擔、癲癇治療的差異、中風復健的需求以及創傷相關疾病，但由於專家數量有限、基礎設施不足、醫療設備成本高昂、植入隨訪體係不完善以及與其他醫療保健優先事項的競爭，腦植入的普及受到限制。

腦植入主要群體分析

東南亞國協正透過擴大三級醫療機構、拓展醫療設備進口管道以及滿足日益成長的先進神經系統治療需求，加強其在腦植入領域的影響力。然而，高所得都市區醫療體系與資源匱乏地區在技術應用上有顯著差異。海灣合作理事會（GCC）國家憑藉其高品質的醫療基礎設施、國際臨床合作以及強大的神經科醫生網路，在先進植入式神經技術的推廣應用方面發揮關鍵作用，並擁有完善的報銷機制和集中採購系統。歐盟透過統一的醫療設備法規、跨境臨床研究網路、資料保護要求以及優先考慮安全性、臨床證據和價值導向的醫療技術評估流程，為腦植入領域提供了最完善的環境之一。金磚國家（BRICS）擁有大規模的神經系統疾病患者群體、不斷提升的國內醫療技術能力和日益增強的臨床研究能力，但也面臨著監管實施時間不一致、經濟障礙以及專業基礎設施差異等挑戰。七國集團憑藉其先進的神經科學研究、完善的監管體系、積極的臨床試驗活動、專業的醫院網路以及先進的保險報銷評估系統，在腦植入創新領域繼續發揮核心作用。同時，北約成員國也透過國防資助的神經技術研究、創傷性腦損傷復健計畫以及與神經介面、網路安全、增強人體機能的應用和敏感神經資料保護相關的兩用管治問題，間接影響著這一領域。

主要國家腦植入趨勢

美國在腦植入領域擁有領先的環境，這得益於其強大的神經外科技術、積極的臨床實驗醫療設備核准流程、一流的大學附屬醫療中心，以及在主導適應症中廣泛應用深部腦植入和反應性神經刺激。加拿大透過專業的神經病學中心和公共醫療保健評估來支持腦植入技術的應用，並強調實證醫學的普及和長期的患者管理。在墨西哥，大都會圈的私人醫療保健系統對腦植入的需求不斷成長，但成本效益和專科醫生的集中度影響了患者的就診機會。巴西擁有拉丁美洲最先進的神經病學專科醫療體系之一，但公立和私立醫療保健之間的差異影響了患者接受腦植入手術的機會。英國將強大的神經科學研究能力與國家醫療服務體系（NHS）對治療結果和成本效益的系統性臨床評估和審查相結合。德國的特點是醫療設備環境成熟、神經外科技術強大，以及植入式神經刺激技術的廣泛臨床應用。法國受益於先進的公立醫院網路和植入式醫療設備的嚴格臨床評估。同時，義大利和西班牙的需求受到人口老化、大學附屬醫院和神經科轉診網路的支撐。俄羅斯主要城市擁有專業的神經外科手術能力，但由於准入、採購和監管方面的複雜性而面臨許多限制。中國正透過政府主導的神經科學舉措、醫院擴建以及自主研發醫療器械，加速推動腦植入式醫療設備的醫療設備和臨床應用。印度在神經系統疾病治療方面存在巨大的未滿足需求，私營部門正在逐步引入先進的神經外科手術，但成本問題和醫療資源分配不均仍然是重要的障礙。在日本，人口老化、高技術標準和完善的醫療設備法規支撐著人們對神經調控技術的持續關注。澳洲將強大的臨床管治與專業的神經科中心相結合，而韓國則透過先進的電子技術、醫院技術的應用以及積極的生物醫學工程研究來提升自身在該領域的影響力。

為腦植入產業領導者提供的實用建議

產業領導者應優先考慮已通過臨床檢驗的應用案例，這些案例需展現植入式神經技術的可衡量效益、持續安全性以及明確的患者選擇標準。研發團隊應投資於封閉回路型功能、低功耗電子元件、生物相容性材料、安全的無線遙測技術以及直覺易用的臨床醫生程式介面，同時確保醫療設備軟體、人工智慧模型和網路安全措施在整個生命週期內均符合法規要求。證據策略應包括前瞻性臨床試驗、真實世界表現監測、病患報告結果、提取設備的分析、不利事件審查以及長期追蹤研究，以增強保險公司的信心並促進醫師採納。各機構也應與神經外科醫師、神經內科醫師、精神科醫師、復健專家、倫理學家、網路安全專家和病患權益倡導團體建立跨學科夥伴關係。商業策略不應僅關注設備植入本身，還應考慮報銷、植入手術培訓、服務基礎設施、遠端監測、電池管理和植入後支援等因素。道德領導力至關重要，神經元資料管治、知情同意、可解釋的演算法行為、公平獲取以及對非治療性增強的限制等問題應在產品設計和臨床部署的早期階段加以解決。

腦植入分析的調查方法

針對腦植入的可靠調查方法應結合一手研究和二手研究，檢驗技術趨勢、臨床應用促進因素、調節路徑和競爭因素，避免依賴未經證實的假設。一手研究應包括對神經外科醫生、神經內科醫生、生物醫學工程師、醫院採購負責人、監管專家、保險公司、復健臨床醫生、網路安全專家和患者代表的訪談。二手研究應從同行評審期刊、臨床試驗註冊庫、監管資料庫、醫療技術評估文件、醫院規程出版物、專利申請、公共衛生資料集、不利事件庫以及與醫療設備、網路安全、軟體生命週期管理和資料保護相關的標準中收集資訊。分析時，證據應按技術類型、臨床適應症、植入部位、最終用戶、手術流程和地區進行分類。數據三角驗證至關重要，尤其對於腦機介面和人工智慧驅動的神經解碼而言，有助於區分已驗證的臨床應用和早期實驗。品管應包括檢驗資訊來源、確認日期有效性、消除宣傳性聲明、審查不利事件報告，以及確保與植入式醫療設備和軟體輔助醫療設備的現行監管定義保持一致。

結論

腦植入正邁入一個新時代，其特點是自適應神經調控、人工智慧驅動的訊號解讀、精準手術以及與數位醫療基礎設施的更緊密整合。儘管目前最迫切的機會仍在於臨床檢驗的治療應用，但新興的腦機介面正在拓展恢復溝通功能、支援運動功能以及個人化神經復健等方面的長期應用前景。區域普及程度將繼續取決於神經外科手術能力、保險報銷、監管框架、臨床證據、術後護理體係以及患者的信任度。隨著創新加速，產業成功不僅取決於技術效能，還取決於對神經資料的負責任管治、透明的人工智慧檢驗、長期安全監測以及公平的醫療服務取得。能夠平衡臨床嚴謹性和倫理設計與可擴展照護模式的相關人員，將最有能力塑造腦植入的未來。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：腦植入市場：依植入類型分類

  • 侵襲型
    • 皮質植入
      • 微電極陣列
      • 猶他小巷
    • 深部腦部刺激
      • 電刺激
      • 磁刺激
    • 神經塵埃
      • 射頻塵埃
      • 超音波粉塵
  • 非侵入性

第8章：腦植入市場：依組件分類

  • 植入式電極
  • 植入式脈衝產生器
  • 神經處理器
  • 訊號發送器
  • 接收器
  • 植入導線
  • 連接器

第9章：腦植入市場：依技術分類

  • 腦機介面
    • 侵入式腦機介面
    • 非侵入式腦機介面
  • 深部腦部刺激
    • 電刺激技術
    • 磁刺激技術
  • 神經塵埃
    • 射頻粉塵技術
    • 超音波除塵技術
  • 光遺傳學
    • 通道視紫質
    • 鹵視紫質

第10章：腦植入市場：依手術類型分類

  • 植入置換手術
  • 植入升級程序
  • 再次手術
  • 植牙手術
    • 開顱手術
    • 微創手術

第11章：腦植入市場：依應用領域分類

  • 消費者
    • 遊戲
    • 健康
  • 診斷
    • 腦圖譜
    • 神經系統疾病監測
  • 治療用途
    • 運動障礙
      • 癲癇
      • 帕金森氏症
    • 疼痛管理
      • 慢性疼痛
      • 神經性疼痛
    • 精神病學
      • 憂鬱症
      • OCD

第12章：腦植入市場：依最終用戶分類

  • 醫院
    • 民眾
    • 私人的
  • 專科神經科中心
  • 神經外科中心
  • 研究機構
  • 學術機構
  • 復健中心

第13章：腦植入市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章：腦植入市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章：腦植入市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co., Ltd.
  • Blackrock Microsystems LLC
  • Boston Scientific Corporation
  • BrainCo, Inc.
  • Ceribell, Inc.
  • ClearPoint Neuro, Inc.
  • Cochlear Limited
  • Compumedics Limited
  • Cyberonics, Inc.
  • g.tec medical engineering GmbH
  • Inbrain Neuroelectronics SL
  • Integra LifeSciences Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • NDI Medical, LLC
  • Neuralink Corporation
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • Neurosoft Bioelectronics SA
  • Nihon Kohden Corporation
  • Paradromics, Inc.
  • Precision Neuroscience Corporation
  • Renishaw PLC
  • Saluda Medical Pty Ltd.
  • Stryker Corporation
  • Synchron, Inc.
Product Code: MRR-C002B1C996EA

The Brain Implants Market is projected to grow by USD 10.51 billion at a CAGR of 9.43% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.59 billion
Estimated Year [2026] USD 6.10 billion
Forecast Year [2032] USD 10.51 billion
CAGR (%) 9.43%

Brain implants are implantable neurotechnology devices designed to interface directly with neural tissue to record, stimulate, modulate, or restore nervous system function. The field spans deep brain stimulation for movement disorders, responsive neurostimulation for epilepsy, cochlear and retinal prosthetic concepts, spinal and cortical interfaces, and emerging brain-computer interface systems for communication and motor control. Demand is being shaped by the documented rise in neurological disease burden, aging populations, improved neurosurgical precision, miniaturized electronics, wireless telemetry, rechargeable power systems, biocompatible materials, and growing clinical evidence for neuromodulation-based treatment pathways. At the same time, the brain implants landscape remains highly regulated because safety, long-term durability, cybersecurity, explainability, informed consent, and post-implant monitoring are central to patient outcomes. Industry participants are increasingly focused on clinically validated indications, human-centered design, reimbursement readiness, real-world evidence generation, and multidisciplinary collaboration across neurology, neurosurgery, psychiatry, rehabilitation, biomedical engineering, and digital health.

Transformative Shifts in the Brain Implants Landscape

The brain implants landscape is shifting from device-centric intervention toward integrated neurotherapeutic ecosystems. Traditional open-loop stimulation is being complemented by closed-loop and adaptive systems that sense neural activity and adjust therapy parameters in response to patient-specific signals. This transition is particularly important in disorders where symptoms fluctuate over time, such as Parkinson's disease, epilepsy, depression, and chronic pain. Advances in microelectrode arrays, flexible neural probes, hermetic packaging, low-power chips, and wireless data transfer are improving the feasibility of long-term implantation while reducing the burden of clinical programming. Another major shift is the convergence of implantable devices with cloud-connected clinical workflows, remote monitoring, digital biomarkers, and precision imaging. Regulatory agencies are also placing greater emphasis on post-market surveillance, software lifecycle management, cybersecurity controls, usability engineering, and evidence of durable clinical benefit. As brain-computer interfaces move from experimental demonstrations toward functional communication and motor-assist applications, ethical governance around autonomy, neural data privacy, identity, equity of access, and enhancement versus therapy is becoming a defining factor in adoption.

Cumulative Impact of Artificial Intelligence on Brain Implants

Artificial intelligence is increasingly embedded across the brain implants value chain, from signal decoding and adaptive stimulation to surgical planning and longitudinal care optimization. In research and clinical development, machine learning supports the interpretation of complex neural recordings, identification of biomarkers, seizure prediction models, movement-state classification, speech decoding, and patient-specific therapy personalization. In clinical settings, AI-enabled tools can help analyze electrophysiological patterns, imaging data, and symptom diaries to support programming decisions and improve the consistency of therapy management. The most significant cumulative impact lies in closed-loop neuromodulation, where algorithms translate real-time neural signals into dynamic stimulation adjustments, potentially improving therapeutic precision while minimizing adverse effects and energy consumption. However, AI also introduces new requirements for validation, transparency, bias evaluation, data provenance, cybersecurity, human factors testing, and clinician oversight. Because neural data can reveal sensitive information about cognition, emotion, and behavior, AI governance in brain implants must go beyond conventional medical device compliance and address privacy, consent, auditability, and human control throughout the device lifecycle.

Key Regional Insights for Brain Implants

Asia-Pacific is advancing rapidly in brain implants due to expanding neurology infrastructure, large patient populations with neurological disorders, strong public investment in medical technology, and growing clinical research activity in China, Japan, South Korea, India, and Australia. North America remains a highly influential region for implantable neurotechnology because of established neurosurgical centers, early clinical trial activity, recognized investigational device pathways, strong reimbursement structures for approved neuromodulation indications, and mature regulatory frameworks for high-risk medical devices. Latin America is characterized by improving access to advanced neurological care in major urban centers, with Brazil and Mexico playing important roles in specialist treatment adoption, although affordability, reimbursement variability, and uneven distribution of neurosurgical expertise remain practical constraints. Europe benefits from coordinated clinical standards, strong academic neuroscience networks, data protection requirements, and robust medical device regulation, with demand supported by aging demographics and public health systems that evaluate evidence, safety, and cost-effectiveness. The Middle East is investing in specialized hospitals, medical tourism, and advanced neurology services, particularly in Gulf economies, while broader regional adoption depends on workforce development, cross-border clinical partnerships, and sustainable reimbursement. Africa presents long-term need driven by neurological disease burden, epilepsy treatment gaps, stroke rehabilitation needs, and trauma-related conditions, but access to brain implants is limited by specialist availability, infrastructure gaps, device affordability, post-implant follow-up capacity, and competing healthcare priorities.

Key Group Insights for Brain Implants

ASEAN countries are strengthening their role in brain implants through expanding tertiary hospitals, medical device import channels, and growing demand for advanced neurological treatment, although adoption differs substantially between higher-income urban healthcare systems and resource-constrained settings. The GCC is emphasizing premium healthcare infrastructure, international clinical partnerships, and specialist neurology capacity, making it an important group for advanced implantable neurotechnology adoption where reimbursement and centralized procurement support access. The European Union provides one of the most structured environments for brain implants through harmonized medical device regulation, cross-border clinical research networks, data protection requirements, and health technology assessment processes that prioritize safety, clinical evidence, and value-based adoption. BRICS economies combine large neurological patient populations, increasing domestic medical technology capabilities, and expanding clinical research capacity, but they also face heterogeneous regulatory timelines, affordability barriers, and differences in specialist infrastructure. G7 countries remain central to brain implant innovation because of advanced neuroscience research, established regulatory science, high clinical trial activity, specialist hospital networks, and sophisticated reimbursement evaluation, while NATO members indirectly shape the field through defense-funded neurotechnology research, rehabilitation programs for traumatic brain injury, and dual-use governance concerns related to neural interfaces, cybersecurity, human performance applications, and protection of sensitive neural data.

Key Country Insights for Brain Implants

The United States is a leading environment for brain implants due to strong neurosurgical expertise, active investigational device pathways, major academic medical centers, and established use of deep brain stimulation and responsive neurostimulation in approved indications. Canada supports adoption through specialized neurological centers and public healthcare evaluation, with emphasis on evidence-based access and long-term patient management. Mexico is seeing growing demand in metropolitan private healthcare systems, although affordability and specialist concentration influence access. Brazil has one of Latin America's strongest specialist healthcare bases for advanced neurology, while public-private disparities affect procedure availability. The United Kingdom combines neuroscience research strength with structured clinical evaluation and national health system scrutiny of outcomes and cost-effectiveness. Germany has a mature medical device environment, strong neurosurgical capacity, and broad clinical use of implantable neurostimulation technologies. France benefits from advanced public hospital networks and rigorous clinical assessment of implantable devices, while Italy and Spain show demand supported by aging populations, university hospitals, and neurology referral networks. Russia has specialized neurosurgical capabilities in major centers but faces constraints linked to access, procurement, and regulatory complexity. China is accelerating brain implant research and clinical capacity through government-backed neuroscience initiatives, hospital expansion, and domestic device development. India has significant unmet neurological care needs and growing private-sector adoption of advanced neurosurgery, though affordability and uneven access remain important barriers. Japan's aging population, high technical standards, and established medical device regulation support continued interest in neuromodulation. Australia combines strong clinical governance with specialized neurology centers, and South Korea is strengthening its role through advanced electronics, hospital technology adoption, and active biomedical engineering research.

Actionable Recommendations for Brain Implant Industry Leaders

Industry leaders should prioritize clinically validated use cases where implantable neurotechnology demonstrates measurable benefit, durable safety, and clear patient selection criteria. Development teams should invest in closed-loop capabilities, low-power electronics, biocompatible materials, secure wireless telemetry, and intuitive clinician programming interfaces while ensuring that device software, AI models, and cybersecurity controls meet lifecycle regulatory expectations. Evidence strategies should include prospective clinical studies, real-world performance monitoring, patient-reported outcomes, explant analysis, adverse event review, and long-term follow-up to support payer confidence and physician adoption. Organizations should also build multidisciplinary partnerships with neurosurgeons, neurologists, psychiatrists, rehabilitation specialists, ethicists, cybersecurity experts, and patient advocacy groups. Commercial strategies should account for reimbursement, implant procedure training, service infrastructure, remote monitoring, battery management, and post-implant support rather than focusing only on device placement. Ethical leadership is essential: neural data governance, informed consent, explainable algorithmic behavior, equitable access, and limits on non-therapeutic enhancement should be addressed early in product design and clinical deployment.

Research Methodology for Brain Implants Analysis

A robust research methodology for brain implants should combine primary and secondary research to validate technology trends, clinical adoption factors, regulatory pathways, and competitive dynamics without relying on unsupported assumptions. Primary inputs should include interviews with neurosurgeons, neurologists, biomedical engineers, hospital procurement specialists, regulatory experts, payers, rehabilitation clinicians, cybersecurity specialists, and patient representatives. Secondary research should draw from peer-reviewed journals, clinical trial registries, regulatory databases, health technology assessment documents, hospital protocol publications, patent filings, public health datasets, adverse event repositories, and standards related to medical devices, cybersecurity, software lifecycle management, and data protection. The analysis should segment evidence by technology type, clinical indication, implant location, end user, procedure workflow, and geography. Data triangulation is essential to distinguish proven clinical use from early-stage experimentation, especially in brain-computer interfaces and AI-enabled neural decoding. Quality controls should include source verification, date relevance checks, exclusion of promotional claims, review of adverse event reporting, and alignment with current regulatory definitions for implantable and software-enabled medical devices.

Conclusion

Brain implants are moving into a new era defined by adaptive neuromodulation, AI-enabled signal interpretation, precision surgery, and stronger integration with digital health infrastructure. The most immediate opportunities remain in clinically validated therapeutic applications, while emerging brain-computer interfaces are expanding the long-term possibilities for communication restoration, motor assistance, and personalized neurorehabilitation. Regional adoption will continue to depend on neurosurgical capacity, reimbursement, regulatory readiness, clinical evidence, post-implant care infrastructure, and patient trust. As innovation accelerates, industry success will be determined not only by engineering performance but also by responsible governance of neural data, transparent AI validation, long-term safety monitoring, and equitable access. Stakeholders that align clinical rigor with ethical design and scalable care models will be best positioned to shape the future of brain implants.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Brain Implants Market, by Implant Type

  • 7.1. Introduction
  • 7.2. Invasive
    • 7.2.1. Cortical Implants
      • 7.2.1.1. Microelectrode Array
      • 7.2.1.2. Utah Array
    • 7.2.2. Deep Brain Stimulation
      • 7.2.2.1. Electrical Stimulation
      • 7.2.2.2. Magnetic Stimulation
    • 7.2.3. Neural Dust
      • 7.2.3.1. Rf Dust
      • 7.2.3.2. Ultrasonic Dust
  • 7.3. Non Invasive

8. Brain Implants Market, by Component

  • 8.1. Introduction
  • 8.2. Implantable Electrodes
  • 8.3. Implantable Pulse Generators
  • 8.4. Neural Processors
  • 8.5. Signal Transmitters
  • 8.6. Receivers
  • 8.7. Implant Leads
  • 8.8. Connectors

9. Brain Implants Market, by Technology

  • 9.1. Introduction
  • 9.2. Brain Computer Interface
    • 9.2.1. Invasive BCI
    • 9.2.2. Non Invasive BCI
  • 9.3. Deep Brain Stimulation
    • 9.3.1. Electrical Stimulation Tech
    • 9.3.2. Magnetic Stimulation Tech
  • 9.4. Neural Dust
    • 9.4.1. Rf Dust Tech
    • 9.4.2. Ultrasonic Dust Tech
  • 9.5. Optogenetics
    • 9.5.1. Channelrhodopsin
    • 9.5.2. Halorhodopsin

10. Brain Implants Market, by Procedure Type

  • 10.1. Introduction
  • 10.2. Implant Replacement Procedures
  • 10.3. Implant Upgrade Procedures
  • 10.4. Revision Procedures
  • 10.5. Implantation Surgery
    • 10.5.1. Open Craniotomy Procedures
    • 10.5.2. Minimally Invasive Procedures

11. Brain Implants Market, by Application

  • 11.1. Introduction
  • 11.2. Consumer
    • 11.2.1. Gaming
    • 11.2.2. Wellness
  • 11.3. Diagnostic
    • 11.3.1. Brain Mapping
    • 11.3.2. Neurological Disorder Monitoring
  • 11.4. Therapeutic
    • 11.4.1. Movement Disorder
      • 11.4.1.1. Epilepsy
      • 11.4.1.2. Parkinsons Disease
    • 11.4.2. Pain Management
      • 11.4.2.1. Chronic Pain
      • 11.4.2.2. Neuropathic Pain
    • 11.4.3. Psychiatry
      • 11.4.3.1. Depression
      • 11.4.3.2. OCD

12. Brain Implants Market, by End User

  • 12.1. Introduction
  • 12.2. Hospitals
    • 12.2.1. Public
    • 12.2.2. Private
  • 12.3. Specialty Neurology Centers
  • 12.4. Neurosurgery Centers
  • 12.5. Research Institutes
  • 12.6. Academic Institutions
  • 12.7. Rehabilitation Centers

13. Brain Implants Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Brain Implants Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Brain Implants Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Aleva Neurotherapeutics SA
  • 17.3. Beijing PINS Medical Co., Ltd.
  • 17.4. Blackrock Microsystems LLC
  • 17.5. Boston Scientific Corporation
  • 17.6. BrainCo, Inc.
  • 17.7. Ceribell, Inc.
  • 17.8. ClearPoint Neuro, Inc.
  • 17.9. Cochlear Limited
  • 17.10. Compumedics Limited
  • 17.11. Cyberonics, Inc.
  • 17.12. g.tec medical engineering GmbH
  • 17.13. Inbrain Neuroelectronics S.L.
  • 17.14. Integra LifeSciences Corporation
  • 17.15. LivaNova PLC
  • 17.16. Medtronic PLC
  • 17.17. MicroTransponder, Inc.
  • 17.18. NDI Medical, LLC
  • 17.19. Neuralink Corporation
  • 17.20. Neuronetics, Inc.
  • 17.21. NeuroPace, Inc.
  • 17.22. Neurosoft Bioelectronics SA
  • 17.23. Nihon Kohden Corporation
  • 17.24. Paradromics, Inc.
  • 17.25. Precision Neuroscience Corporation
  • 17.26. Renishaw PLC
  • 17.27. Saluda Medical Pty Ltd.
  • 17.28. Stryker Corporation
  • 17.29. Synchron, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN IMPLANTS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BRAIN IMPLANTS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BRAIN IMPLANTS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BRAIN IMPLANTS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BRAIN IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BRAIN IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL BRAIN IMPLANTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL BRAIN IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORTICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORTICAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORTICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MICROELECTRODE ARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROELECTRODE ARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROELECTRODE ARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UTAH ARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UTAH ARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UTAH ARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEURAL DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEURAL DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEURAL DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RF DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RF DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RF DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASONIC DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASONIC DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASONIC DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE ELECTRODES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE ELECTRODES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE ELECTRODES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE PULSE GENERATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE PULSE GENERATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE PULSE GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEURAL PROCESSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEURAL PROCESSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEURAL PROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SIGNAL TRANSMITTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SIGNAL TRANSMITTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SIGNAL TRANSMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RECEIVERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RECEIVERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RECEIVERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANT LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANT LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANT LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONNECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONNECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONNECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN COMPUTER INTERFACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN COMPUTER INTERFACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN COMPUTER INTERFACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INVASIVE BCI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INVASIVE BCI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INVASIVE BCI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON INVASIVE BCI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON INVASIVE BCI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NON INVASIVE BCI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ELECTRICAL STIMULATION TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ELECTRICAL STIMULATION TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ELECTRICAL STIMULATION TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC STIMULATION TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC STIMULATION TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC STIMULATION TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEURAL DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEURAL DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEURAL DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RF DUST TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RF DUST TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RF DUST TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ULTRASONIC DUST TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ULTRASONIC DUST TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ULTRASONIC DUST TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL OPTOGENETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL OPTOGENETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL OPTOGENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CHANNELRHODOPSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CHANNELRHODOPSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CHANNELRHODOPSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HALORHODOPSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HALORHODOPSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HALORHODOPSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMPLANT REPLACEMENT PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IMPLANT REPLACEMENT PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMPLANT REPLACEMENT PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IMPLANT UPGRADE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMPLANT UPGRADE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IMPLANT UPGRADE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL REVISION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL REVISION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL REVISION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IMPLANTATION SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMPLANTATION SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IMPLANTATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OPEN CRANIOTOMY PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OPEN CRANIOTOMY PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OPEN CRANIOTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONSUMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONSUMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CONSUMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GAMING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GAMING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GAMING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL WELLNESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL WELLNESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL WELLNESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MAPPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MAPPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MAPPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGICAL DISORDER MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGICAL DISORDER MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGICAL DISORDER MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MOVEMENT DISORDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MOVEMENT DISORDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MOVEMENT DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PARKINSONS DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PARKINSONS DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PARKINSONS DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PSYCHIATRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PSYCHIATRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PSYCHIATRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL OCD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL OCD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL OCD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL SPECIALTY NEUROLOGY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL SPECIALTY NEUROLOGY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL SPECIALTY NEUROLOGY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 306. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 308. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 310. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 312. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 314. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 316. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 322. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 324. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 326. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 328. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 329. NATO BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 330. NATO BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. NATO BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 332. NATO BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 333. NATO BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 334. NATO BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 335. NATO BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 336. NATO BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. NATO BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 338. NATO BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 339. NATO BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 340. NATO BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 341. NATO BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. NATO BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 343. NATO BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 344. NATO BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 345. NATO BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 346. NATO BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 347. NATO BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 348. NATO BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 349. NATO BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 350. NATO BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. NATO BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 352. G7 BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 353. G7 BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. G7 BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 355. G7 BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 356. G7 BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 357. G7 BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 358. G7 BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 359. G7 BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 360. G7 BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 361. G7 BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 362. G7 BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
  • TABLE 363. G7 BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
  • TABLE 364. G7 BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. G7 BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
  • TABLE 366. G7 BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 367. G7 BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
  • TABLE 368. G7 BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 369. G7 BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 370. G7 BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
  • TABLE 371. G7 BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 372. G7 BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
  • TABLE 373. G7 BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 374. G7 BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 375. BRICS BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 376. BRICS BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 377. BRICS BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 378. BRICS BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 379. BRICS BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 380. BRICS BRAIN IMPLANTS MARKET SIZE, BY N